We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hip Replacement Riskier for Rheumatoid Arthritis Sufferers

By HospiMedica International staff writers
Posted on 11 Dec 2013
Patients with rheumatoid arthritis (RA) are at higher risk than those with osteoarthritis (OA) for adverse outcomes following joint replacement surgery, according to a new study.

Researchers at the University of Toronto (Canada) identified 43,997 patients who underwent a first primary elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) procedure between 2002 and 2009. More...
Using a validated algorithm for identifying individuals with RA, they then compared the rates of complications among THA and TKA recipients with versus without RA. The relationship between arthritis type and the occurrence of specific complications was adjusted for potential confounders (age, sex, comorbidity, and provider volume).

The results showed that recipients with RA had higher age and sex-standardized rates of dislocation following THA, and higher rates of infection following TKA. After adjustment for potential confounders, a diagnosis of RA was a significant and independent predictor of dislocation following THA, with a risk almost double that of OA. Risk for infection within two years of TKA was also high, relative to recipients with OA. The study was published on November 19, 2013, in Arthritis and Rheumatism.

“Dislocation within a short time of total hip arthroplasty is a serious complication,” concluded lead author Bheeshma Ravi, MD, and colleagues of the department of orthopedic surgery. “In addition to being very painful and necessitating revision arthroplasty and/or aggressive rehabilitation following closed reduction, it is estimated that dislocations increase the hospital costs of a primary total hip arthroplasty by over 300%.”

According to the researchers, possible explanations as to why patients with RA were more likely to experience dislocation were the use of smaller implants and different surgical techniques, along with disease-related factors such as acetabular protrusion and soft tissue problems. Explanations as to why infections were more common in the RA group included the use of immunomodulatory treatments, but it was not clear why the increased risk was only for knee replacement, and not also for the hip.

Related Links:

University of Toronto



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.